Gemma A Figtree

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

James Chong

Professor of Cardiovascular Medicine

University of Sydney

AUSTRALIA

View details

John O'Sullivan

Professor of Cardiometabolic Medicine

University of Sydney

AUSTRALIA

View details

David Celermajer

Professor of Cardiology

University of Sydney

AUSTRALIA

View details

Charalambos Antoniades

University of Oxford

UNITED KINGDOM

View details

Martin Ugander

Professor

University of Sydney

AUSTRALIA

View details

Clare Arnott

AUSTRALIA

View details

Michael Patrick Gray

University of Sydney

AUSTRALIA

View details

Yan Yee Mark Chan

Associate Professor with tenure

National University of Singapore (NUS)

SINGAPORE

View details

Elijah Genetzakis

University of Sydney

AUSTRALIA

View details

Roger Blumenthal

Johns Hopkins University School of Medicine

UNITED STATES

View details

Michael Blaha

UNITED STATES

View details

Peter Meikle

Head

Baker Heart and Diabetes Institute

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gemma A Figtree

Research Interests

Explore related searches

Contact this professor

Articles (9)

Reassurance for parents with children bornvia assisted reproductive technology or too soon to tell?

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors

Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development

High‐Resolution Transthoracic Echocardiography Accurately Detects Pulmonary Arterial Pressure and Decreased Right Ventricular Contractility in a Mouse Model of Pulmonary Fibrosis and Secondary Pulmonary Hypertension

Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry

Human susceptibility to coronary artery disease: lessons from chimpanzee resilience

Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk‐Enhancing Factor in the Pooled Cohort Equation: A Cost‐Effectiveness Analysis Study

Collaborators (12)

James Chong

John O'Sullivan

David Celermajer

Charalambos Antoniades

Martin Ugander

Clare Arnott

Michael Patrick Gray

Yan Yee Mark Chan

Elijah Genetzakis

Roger Blumenthal

Michael Blaha

Peter Meikle

Make your next move.